Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Chung Kevin. Director active across 1 company, notably SeaStar Medical Holding Corp. Aggregated, 14 disclosures have been recorded. Breakdown: 7 buys · 0 sell. Total volume traded: €37k. Activity tracked since 5 April 2022. The latest transaction was disclosed on 6 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chung Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,760 shares@ US$1.8521.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000929638-23-001129:0
Canonical exit: 4 Jul 2022 (T+90)
14 of 14 declarations
About Chung Kevin
Chung Kevin is Chief Medical Officer at SeaStar Medical Holding Corp (XNAS). He has 14 filings in total, and across the 14 sampled filings all are acquisitions, with buy volume of EUR 37203 and no sell volume, with filings dated from 2023-04-07 to 2026-02-10.